Alteogen has signed an exclusive licensing deal worth up to $365m with a global pharmaceutical company, granting worldwide rights to...
Azra AI and Blackford have formed a partnership to support the progression from imaging-based detection to care coordination for patients...
SystImmune has dosed the first patient in its global Phase III clinical trial, BrenDeLL-Lung01, assessing BL-M14D1 combined with atezolizumab in...
SOPHiA GENETICS and AstraZeneca are to co-develop and launch two companion diagnostics aimed at supporting precision oncology therapies.The post SOPHiA...
Evexta Bio and Roche have partnered on a Phase Ib study investigating the rupitasertib-giredestrant combination in patients with advanced or...
Phylo has collaborated with Chugai Pharmaceutical to implement the Biomni Lab platform within the latter’s drug discovery operations.The post Phylo...
Integer Holdings is to be acquired by an affiliate of investment funds managed by KKR, in an all-cash deal valuing...
Ascletis Pharma has begun a global Phase III clinical programme for its once-daily oral small molecule GLP-1 receptor agonist, ASC30,...
CapVest Partners-backed Curium has agreed to acquire rival US-based radiopharmaceutical company Lantheus in an all-cash deal worth up to nearly...
Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.